NAD+ and Cellular Aging

NAD+ exists in two forms: NAD+ (oxidized) and NADH (reduced). The ratio between them reflects the redox state of the cell. As an electron carrier, NAD+/NADH is essential for:

Beyond energy metabolism, NAD+ is consumed (not just cycled) by a second class of enzymes — making its total cellular concentration a critical variable.

Sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases and ADP-ribosyltransferases. Each sirtuin consumes one molecule of NAD+ per reaction, converting it to nicotinamide and O-acetyl-ADP-ribose.

Because sirtuins require NAD+ as a co-substrate (not just a cofactor), their activity is directly limited by NAD+ availability. When cellular NAD+ is high, sirtuins are active. When NAD+ falls — as it does with age — sirtuin activity declines.

Sirtuin functions relevant to aging: - SIRT1: Regulates PGC-1α (mitochondrial biogenesis), p53 (DNA damage response), NF-κB (inflammation) - SIRT3: Major mitochondrial deacetylase; maintains ETC efficiency and reduces ROS - SIRT6: Critical for DNA double-strand break repair; knockout mice age prematurely - SIRT7: Ribosome biogenesis and metabolic homeostasis

PARPs (poly ADP-ribose polymerases) are the other major NAD+-consuming enzyme family. PARP1 is activated by DNA damage and rapidly polymerizes ADP-ribose chains onto histones and other proteins to recruit DNA repair machinery.

In conditions of high DNA damage (aging, radiation, oxidative stress), PARP1 becomes hyperactivated and dramatically depletes cellular NAD+. This creates a vicious cycle: DNA damage → PARP activation → NAD+ depletion → sirtuin suppression → impaired DNA repair → more damage.

This PARP-mediated NAD+ drain is a key reason NAD+ falls with age — aged cells accumulate more DNA damage, activating more PARP.

Human and rodent studies have documented a ~50% decline in tissue NAD+ levels between young adulthood and middle/old age. This decline is not uniform — metabolically active tissues (muscle, liver, brain) show the most significant drops.

Consequences observed in research models: - Mitochondrial dysfunction and reduced energy production - Impaired DNA damage response - Increased cellular senescence - Disrupted circadian rhythm regulation (SIRT1 regulates clock genes) - Reduced insulin sensitivity

NAD+ precursor supplementation (NMN, NR) in aged mice has restored NAD+ levels to younger ranges and reversed many of these phenotypes, driving significant investment in human NAD+ research.

Oral NAD+ precursors (NMN, NR) are the most common research approach due to bioavailability challenges with NAD+ itself. However, IV NAD+ administration bypasses GI metabolism and allows direct tissue delivery.

IV NAD+ studies have examined: rapid restoration of cellular NAD+ pools, acute effects on metabolic and inflammatory parameters, and potential applications in addiction and neurology (where IV has been clinically used off-label). Research protocols vary significantly; investigators should consult published literature for specific methodology.